tradingkey.logo
搜尋

Eikon Therapeutics Ord Shs

EIKN
添加自選
9.210USD
-0.410-4.26%
收盤 07-31 16:00美東報價延遲15分鐘
498.62M總市值
虧損本益比TTM

Eikon Therapeutics Ord Shs

9.210
-0.410-4.26%

關於 Eikon Therapeutics Ord Shs 公司

Eikon Therapeutics Ord Shs簡介

公司代碼EIKN
公司名稱Eikon Therapeutics Inc
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)
員工數量384
證券類型Ordinary Share
年結日Feb 05
公司地址230 Harriet Tubman Way
城市MILLBRAE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94030
電話13026587581
網址https://eikontx.com/
公司代碼EIKN
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)

Eikon Therapeutics Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Mr. Joshua Wolfe
Mr. Joshua Wolfe
Director
Director
--
--
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Mr. Joshua Wolfe
Mr. Joshua Wolfe
Director
Director
--
--
,
,
--
--

常見問題

Eikon Therapeutics Ord Shs的前五大股東是誰?

Eikon Therapeutics Ord Shs的前五大股東如下:Dr. Roger M. Perlmutter, M.D., Ph.D.
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有